Danny Cheung1, Shyam Menon2, Jonathan Hoare3, Anjan Dhar4, Nigel Trudgill5. 1. Sandwell General Hospital, Lyndon, West Bromwich, UK. 2. New Cross Hospital, Wolverhampton Road, Wolverhampton, UK. 3. St Mary's Hospital, Praed Street, London, UK. 4. Darlington Memorial Hospital, Hollyhurst Road, Darlington, UK. 5. Sandwell General Hospital, Lyndon, West Bromwich, UK. nigel.trudgill@nhs.net.
Abstract
BACKGROUND AND AIMS: Up to 14 % of upper gastrointestinal cancer (UGIC) subjects underwent esophago-gastro-duodenoscopy (EGD) in the preceding 3 years, which did not detect UGIC. The frequency of such events and associated risk factors was evaluated. METHODS: UGIC subjects were identified from a UK primary care database. Post-EGD upper gastrointestinal cancers (PEUGIC) cases were subjects undergoing EGD 12-36 months prior to UGIC diagnosis. Controls had not undergone EGD during the same period. Logistic regression analysis examined associations with PEUGIC. RESULTS: 4249 gastric cancer (GC) subjects (44.8 %) and 5238 esophageal cancer (EC) subjects (55.2 %) were analyzed. There were 633 (6.7 %) PEUGIC subjects [279 EC and 354 GC]. Multivariate analysis revealed that younger age [OR 1.02, (95 % CI 1.01-1.03), p < 0.0001], female gender [1.39 (1.17-1.64), p < 0.0001], increasing comorbidity [1.35 (1.13-1.61), p < 0.0001], and greater deprivation [1.31 (1.09-1.59), p = 0.005] were associated with PEUGIC. Alarm symptoms on presentation [0.32 (0.26-0.40), p < 0.0001] were less likely to be associated with PEUGIC. GC was more likely to be associated with PEUGIC than EC [1.33 (1.13-1.58), p = 0.001]. PEUGIC EGDs reported findings associated with UGIC (stricture or ulceration) in 8.3 % of cases, and only 60.9 % had a follow-up EGD within 90 days. PEUGIC rate declined from 7.9 to 2.7 % for EC and 9.0-6.5 % for GC during the study period. CONCLUSIONS: PEUGIC occurs in 6.7 % of UGIC. PEUGIC was associated with GC, younger age, female gender, increasing comorbidity and deprivation, and a lack of alarm symptoms.
BACKGROUND AND AIMS: Up to 14 % of upper gastrointestinal cancer (UGIC) subjects underwent esophago-gastro-duodenoscopy (EGD) in the preceding 3 years, which did not detect UGIC. The frequency of such events and associated risk factors was evaluated. METHODS: UGIC subjects were identified from a UK primary care database. Post-EGD upper gastrointestinal cancers (PEUGIC) cases were subjects undergoing EGD 12-36 months prior to UGIC diagnosis. Controls had not undergone EGD during the same period. Logistic regression analysis examined associations with PEUGIC. RESULTS: 4249 gastric cancer (GC) subjects (44.8 %) and 5238 esophageal cancer (EC) subjects (55.2 %) were analyzed. There were 633 (6.7 %) PEUGIC subjects [279 EC and 354 GC]. Multivariate analysis revealed that younger age [OR 1.02, (95 % CI 1.01-1.03), p < 0.0001], female gender [1.39 (1.17-1.64), p < 0.0001], increasing comorbidity [1.35 (1.13-1.61), p < 0.0001], and greater deprivation [1.31 (1.09-1.59), p = 0.005] were associated with PEUGIC. Alarm symptoms on presentation [0.32 (0.26-0.40), p < 0.0001] were less likely to be associated with PEUGIC. GC was more likely to be associated with PEUGIC than EC [1.33 (1.13-1.58), p = 0.001]. PEUGIC EGDs reported findings associated with UGIC (stricture or ulceration) in 8.3 % of cases, and only 60.9 % had a follow-up EGD within 90 days. PEUGIC rate declined from 7.9 to 2.7 % for EC and 9.0-6.5 % for GC during the study period. CONCLUSIONS: PEUGIC occurs in 6.7 % of UGIC. PEUGIC was associated with GC, younger age, female gender, increasing comorbidity and deprivation, and a lack of alarm symptoms.
Entities:
Keywords:
Early detection of cancer; Endoscopy; Esophageal cancer; Gastric cancer
Authors: Georgina Chadwick; Oliver Groene; Stuart Riley; Richard Hardwick; Tom Crosby; Jonathan Hoare; George B Hanna; Kimberley Greenaway; David A Cromwell Journal: Clin Gastroenterol Hepatol Date: 2015-01-30 Impact factor: 11.382
Authors: James D Lewis; Rita Schinnar; Warren B Bilker; Xingmei Wang; Brian L Strom Journal: Pharmacoepidemiol Drug Saf Date: 2007-04 Impact factor: 2.890
Authors: Neena Abraham; Alan Barkun; Martin Larocque; Carlo Fallone; Serge Mayrand; Vicky Baffis; Albert Cohen; Donald Daly; Habib Daoud; Lawrence Joseph Journal: Gastrointest Endosc Date: 2002-08 Impact factor: 9.427
Authors: Enrique Rodríguez de Santiago; Nerea Hernanz; Héctor Miguel Marcos-Prieto; Miguel Ángel De-Jorge-Turrión; Eva Barreiro-Alonso; Carlos Rodríguez-Escaja; Andrea Jiménez-Jurado; María Sierra-Morales; Isabel Pérez-Valle; Nadja Machado-Volpato; María García-Prada; Laura Núñez-Gómez; Andrés Castaño-García; Ana García García de Paredes; Beatriz Peñas; Enrique Vázquez-Sequeiros; Agustín Albillos Journal: United European Gastroenterol J Date: 2018-10-31 Impact factor: 4.623